In high-, moderate-, and low-differentiation ovarian cancer tissues, the positivity rates of IGF-1R were 76.19%, 85.71%, and 94.44%, respectively, and no statistical significance was detected among the three group comparisons (P > 0.05). The gene discussed is IGF1R; the disease is ovarian cancer.